Artelo Biosciences stock soars after positive first-in-human study results

1 week ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Artelo Biosciences stock soars after positive first-in-human study results

Related

Bill Gates was right to defend USAID amid Elon Musk’s attacks—take it from someone who experienced its impact

Bill Gates was right to defend USAID amid Elon Musk’s attack...

12 minutes ago 0
CoreWeave's acquisition increases data center footprint: analysts

CoreWeave's acquisition increases data center footprint: ana...

16 minutes ago 0
Southwest Airlines dips after notching six straight sessions of gains

Southwest Airlines dips after notching six straight sessions...

18 minutes ago 0
MP Materials downgraded at Jefferies on limited upside after rally

MP Materials downgraded at Jefferies on limited upside after...

37 minutes ago 0
Tariffs push U.S. tax rates to post-WWII highs, yet USD paradoxically strengthens – Seymour

Tariffs push U.S. tax rates to post-WWII highs, yet USD para...

44 minutes ago 0
SA analyst upgrades/downgrades: GOOS, ANET, QQQ, NET

SA analyst upgrades/downgrades: GOOS, ANET, QQQ, NET

59 minutes ago 0
Blackstone considers joint bid for French telecom firm SFR - report

Blackstone considers joint bid for French telecom firm SFR -...

1 hour ago 0
Geely rolls into Italy as its international expansion continues

Geely rolls into Italy as its international expansion contin...

1 hour ago 0
Trump slaps 25% tariffs on Japan and South Korea—and Wall Street stumbles

Trump slaps 25% tariffs on Japan and South Korea—and Wall St...

1 hour ago 0
Fannie Mae housing sentiment survey declines in June

Fannie Mae housing sentiment survey declines in June

1 hour ago 0
Strategy posts $14 billion unrealized gain in second quarter

Strategy posts $14 billion unrealized gain in second quarter...

1 hour ago 0
AI can make anyone rich: Mark Cuban says it could turn ‘just one dude in a basement’ into a trillionaire

AI can make anyone rich: Mark Cuban says it could turn ‘just...

1 hour ago 0
Shell sinks after warning of weaker profit from gas trading, chemicals businesses

Shell sinks after warning of weaker profit from gas trading,...

1 hour ago 0
Phibro Animal Health soars after J.P. Morgan upgrades on solid execution, higher margins

Phibro Animal Health soars after J.P. Morgan upgrades on sol...

1 hour ago 0
Trump puts 25% tariff on Japan and South Korea

Trump puts 25% tariff on Japan and South Korea

1 hour ago 0
RFK Jr. sued by doctor, health groups over changes to COVID shot recommendations

RFK Jr. sued by doctor, health groups over changes to COVID ...

1 hour ago 0
Ford set to snap six straight sessions of gains

Ford set to snap six straight sessions of gains

2 hours ago 0
Tech Voices: Musk's America Party, Navarro blasts Apple, Robinhood

Tech Voices: Musk's America Party, Navarro blasts Apple, Rob...

2 hours ago 0
Skanska, partners secure $658M contract for rail upgrade in Washington

Skanska, partners secure $658M contract for rail upgrade in ...

2 hours ago 0
Prime Medicine soars as Jones sees it as an acquisition target

Prime Medicine soars as Jones sees it as an acquisition targ...

2 hours ago 0

Trending

Popular

Biggest weekly communication services gainers: Meta Platforms leads

Biggest weekly communication services gainers: Meta Platform...

1 week ago 10
Re: No shortage of bombs, but scarcity of everything to starve Gazans by Israel as war weapon: Palestine

Re: No shortage of bombs, but scarcity of everything to star...

2 weeks ago 9
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved